Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT

ConditionCancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUNC Lineberger Comprehensive Cancer Center

About this trial

This study will assess the feasibility of incorporating biometric data via wearable health technology (WHT) into the radiation oncology (RO) clinic workflow for patients receiving concurrent radiation therapy and systemic therapy (CRT) for cancer. The investigators hypothesize that a practical workflow could be created within a busy community RO practice that will allow providers and patients to readily appreciate physiologic declines during concurrent CRT.

Subjects will be asked to wear a device as part of this study that will collect their biometric data (heart rate, number of steps taken per day, etc) called a WHT device throughout their treatment and for 4 weeks afterward. Subjects will be asked to upload the data from their devices onto the computers in the clinic for the assessment.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All genders aged ≥ 18 years of age.

English-speakers

Able to understand and cooperate with study procedures.

Signed and dated informed consent.

Disqualifiers

None

Trial population

Adult subjects were diagnosed with cancer and prescribed concurrent systemic therapy and radiation therapy and their providers.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

20 Participants
are grouped into 1 trial group
Group A: Biometric Data Collection

Trial outcomes

Primary outcomes

1

The rate of technology adoption

The rate of technology adoption will be quantified as the fraction of subjects who successfully download their WHT data into the research databases in the radiation oncology clinic. Success, on a subject-specific basis, will be defined as their reporting any of their WHT biometric data on \>40% of eligible days.

Time frame
Up to 12 weeks

Secondary outcomes

1

Provider perception of the utility

The physician's and nurse's subjective assessment of the utility of having the subject's wearable health technology data such as enhanced dietary or hydration counseling, supportive medication alteration, and/or intravenous fluid hydration will be quantified, using a survey.

Time frame
Up to 12 weeks
2

Subject perception of the utility

The subjects' responses to the utility of wearable health technology data will be quantified using surveys.

Time frame
Up to 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: